STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns
France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.